Clinician use of 'worry' statements during surrogate decision making in the hospital

临床医生在医院代理决策过程中使用“担忧”陈述

阅读:1

Abstract

OBJECTIVE: Current guidance of how to share a prognosis with patients or surrogate decision makers suggests the use of "I worry" statements. Despite this guidance, there is little known about how "worry" or "concern" statements are used in clinical settings. The purpose of this analysis was to examine the function of "worry" statements in clinician-surrogate decision-making conversations with life-or-death implications. METHODS: We audio recorded 27 clinician-surrogate conversations in two hospitals in one Midwest city in the USA. We used conversation analysis, a qualitative method, to analyze clinicians' use of "worry" statements throughout the corpus and what course of action they were "doing" in the interaction. RESULTS: There were two distinct uses of "worry" statements. Clinicians' use of "worry" statements to convey the gravity of the patient's situation of a poor prognosis seemed to forecast an introduction to limiting treatment as a potential option. When discussing treatment, "worry" statements seemed to have a persuasive function against pursuing treatment. Surrogates often resisted "worry" statements in the discussion of treatment, as these statements conveyed restricting choices that surrogates have the authority to make. CONCLUSION: The balance of the clinician's epistemic authority of the medical understanding of the patient's situation with the surrogate's authority in making a decision is worthy of further exploration. PRACTICE IMPLICATIONS: Surrogate resistance to "worry" statements in the discussion of treatment may be more a function of the persuasion to limit treatment than the "worry" statements themselves. Further research is necessary to determine best practice language during treatment deliberation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。